Israel’s OncoRedox is developing a new platform for the early diagnosis and monitoring of cancer and chronic diseases. Its disposable sensor plus AI-powered technology is designed to detect and profile cell-free metabolites within minutes, providing a unique metabolic fingerprinting.
Blood test to detect cancer
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.